Cardiac Ablation Catheters
In 2019, an estimated 1,115,550 cardiac catheter ablation procedures were performed worldwide, with RoW countries accounting for the largest portion, followed by the US, five major European markets, and Japan. The total number of procedure is expected to increase at a 5.9% growth rate through 2025. Global sales of cardiac ablation catheters were estimated at nearly $2.4bn in 2019, and are expected to increase at a rate of 7.1% through 2025, with sales of cryoballoon, laser-based, and hot-RF devices expected to outpace sales of standard and advanced RF systems. The US, which accounted for the most sales in 2019, is also expected to experience the most rapid growth in this market, with 8.0% from 2019–25. Global demand for cardiac ablation dropped in 2020 as a result of the COVID-19 pandemic, causing a 10% decrease in sales. Sales are expected to return to growth in 2021, with a return to double-digit year-on-year growth starting in 2022. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global cardiac ablation catheters market for 2019–25.